Thromb Haemost 1993; 69(04): 311-315
DOI: 10.1055/s-0038-1651603
Original Article
Clinical Studies
Schattauer GmbH Stuttgart

Problems of Oral Anticoagulation in an Adult with Homozygous Protein C Deficiency and Late Onset of Thrombosis

P Pescatore
1   Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris, France
,
H M Horellou
1   Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris, France
,
J Conard
1   Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris, France
,
M Piffoux
2   Centre Hospitalier d'Auxerre, France
,
P Van Dreden
1   Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris, France
,
A Ruskone-Fourmestraux
3   Service Médecine et Hépato-Gastro-Entérologie, Hôtel-Dieu, Paris, France
,
M Samama
1   Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 27. April 1992

Accepted after revision 07. Dezember 1992

Publikationsdatum:
05. Juli 2018 (online)

Preview

Summary

We describe a 57-year-old woman with homozygous protein C deficiency and mild thrombotic manifestations consisting of three spontaneous distal deep vein thromboses occurring after the age of 45. Previous surgery and pregnancies had been uneventful. Low but detectable protein C antigen and activity levels (both 20%) were discovered on the occasion of skin necrosis induced by oral anticoagulation. This therapy was interrupted because of skin necrosis and several episodes of disseminated intravascular coagulation (DIC) at the initiation of treatment despite a cautious protocol. No recurrent thromboembolic event has occurred in our patient using prophylactic doses of low molecular weight heparin for 24 months. New therapeutic approaches might be the administration of low molecular weight heparin or oral anticoagulation associated with protein C replacement in the induction period. This case reflects the variability of expression of protein C deficiency as well as the potential hazards of antivitamin K anticoagulation in this disorder.